1Bardella MT,Valenti L,Pagliari C,et al.Searching for coeliac disease in patients with non-alcoholic fatty liver disease[J].Dig Liver Dis,2004,36:333-336.
2Kendrick S,Leathart JB,Henderson E,et al.A 'loss-of-function' mutation inTIRAP,the gene encoding the Toll-like receptor adapter moleculeMal protects against fibrosis in NAFLD but not ALD[J].Hepatology,2008,48:334A.
3Samuel VT,Liu ZX,Wang A,et al.Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease[J].J Clin Invest,2007,117:739-745.
4Lee JY,Hwang DH.The modulation of inlammatory gene expression by lipids:mediation through Toll-like receptors[J].Mol Cells,2006,21:174-185.
5Odegaard JI,Ricardo-Gonzalez RR,Goforth MH,et al.Macrophage-speci fic PPARgamma controls alternative activation and improves insulin resistance[J].Nature,2007,447:1116-1120.
6Wouters K,van Gorp PJ,Bieghs V,et al.Dietary cholesterol,rather than liver steatosis,leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis[J].Hepatology,2008,48:474-486.
7Zhou M,Xu A,Tam PK,et al.Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury[J].Hepatology,2008,48:1087-1096.
